Public Health Ethics 4 (2):109-120 (2011)
|Abstract||The majority of deaths due to tobacco in the twenty-first century will occur in the developing world, where over 80% of current tobacco users live. In November 2010 guidelines were adopted for implementing Article 14 of the World Health Organization’s Framework Convention on Tobacco Control (FCTC). The guidelines call on all countries to promote tobacco treatment programs. Nevertheless, some experts argue for a strict focus, at least in developing countries, on population-based measures such as taxes and indoor air laws, which they consider more cost-effective than individual treatment. In this article we defend tobacco dependence treatment in developing countries. First, these experts understate the comparative cost-effectiveness of individual treatment programs. Second, they overlook numerous ethical considerations beyond cost-effectiveness that support individual tobacco treatment in developing countries. We conclude that the strict population-based focus in developing country tobacco control advocated by some experts is misplaced. In general, developing nations should combine population-based measures and individual tobacco treatment programs|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Similar books and articles
Derek Yach (2001). Healthy Investments in Investing in Health. Journal of Business Ethics 33 (3):191 - 198.
Guido Palazzo & Ulf Richter (2005). CSR Business as Usual? The Case of the Tobacco Industry. Journal of Business Ethics 61 (4):387 - 401.
E. Breton & W. Sherlaw (2011). Examining Tobacco Control Strategies and Aims Through a Social Justice Lens: An Application of Sen's Capability Approach. Public Health Ethics 4 (2):149-159.
Robbin Derry & Sachin V. Waikar (2006). Tar Wars. Proceedings of the International Association for Business and Society 17:89-92.
Patrizia Russo, Candida Nastrucci, Giulio Alzetta & Clara Szalai (2011). Tobacco Habit: Historical, Cultural, Neurobiological, and Genetic Features of People's Relationship with an Addictive Drug. Perspectives in Biology and Medicine 54 (4):557-577.
Jonathan Liberman (2012). Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance. Journal of Law, Medicine and Ethics 40 (2):326-347.
Michelle Inness, Julian Barling, Keith Rogers & Nick Turner (2008). De-Marketing Tobacco Through Price Changes and Consumer Attempts Quit Smoking. Journal of Business Ethics 77 (4):405 - 416.
William R. Pasewark & Mark E. Riley (2010). It's a Matter of Principle: The Role of Personal Values in Investment Decisions. [REVIEW] Journal of Business Ethics 93 (2):237 - 253.
David A. Bella (1997). Organized Complexity in Human Affairs: The Tobacco Industry. [REVIEW] Journal of Business Ethics 16 (10):977-999.
O. Lev, B. S. Wilfond & C. M. McBride (2013). Enhancing Children Against Unhealthy Behaviors—An Ethical and Policy Assessment of Using a Nicotine Vaccine. Public Health Ethics 6 (2):197-206.
Debora Diniz (2009). Rationing the Access to High Cost Medicines in Developing Countries. Developing World Bioethics 9 (2).
Nathaniel Wander & Ruth E. Malone (2007). Keeping Public Institutions Invested in Tobacco. Journal of Business Ethics 73 (2):161 - 176.
Robbin Derry & Sachin Waikar (2007). Getting Smoke Off the Screen. Proceedings of the International Association for Business and Society 18:499-499.
Deepak Lal (2000). The Third World and Globalization. Critical Review 14 (1):35-46.
Steven R. Thomsen (1998). Public Relations and the Tobacco Industry: Examining the Debate on Practictioner Ethics. Journal of Mass Media Ethics 13 (3):152 – 164.
Added to index2011-06-09
Total downloads9 ( #122,430 of 722,932 )
Recent downloads (6 months)0
How can I increase my downloads?